Purchase Order HHSN272201100474P
- Not listed
- This is a federal contract award to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The $6,895.00 firm fixed price purchase order was awarded on May 11, 2011 by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) for AMBIS# 1554864NCOUNTER GX CODESET--48 RXNS GXA-P1CS-048 (136 GEN X 48 RXNS). This contract has no set-aside designation. Nanostring is the prime...
- This $93,359 firm fixed-price purchase order was awarded to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of Nanostring's proprietary nCounter and GeoMx analysis systems, reagents, and consumables to support genomic, molecular, and cellular...
- This is a federal contract award to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The contract, valued at $5,883.00, is a firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID) for assay kits. The contract has no set-aside designation. Nanostring has provided a wide range of products and services to various government agencies through past prime and subcontract awards,...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The $50,203.50 firm fixed-price purchase order is for the delivery of Nanostring's specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular, and...
- This contract award to Nanostring Technologies, Inc. is for the delivery of the company's specialized nCounter RNA analysis systems, reagents, and related consumables to support biomedical research and healthcare programs for the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The $6,100 firm fixed-price purchase order includes the supply of nCounter Analysis Systems, which enable multiplexed digital detection and...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Nanostring Technologies, Inc., a for-profit manufacturer of advanced genomic analysis platforms and life science tools. The $9,999 firm fixed price purchase order was awarded on September 20, 2017 without the use of a set-aside program. Nanostring Technologies provides specialized laboratory equipment, reagents, assays, and testing services to support genomic,...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $15,366.00 firm fixed-price purchase order contract to Nanostring Technologies, Inc. for the supply of NANOSTRING TECHNOLOGIES INC (AMBIS #2223210) CONSUMABLE XT TAG SETRNA BIOLOGICAL PRODUCTS. This is a non-set-aside contract with an ultimate completion date of August 1, 2024. Nanostring Technologies, Inc. is a publicly traded provider of life science tools and services, including advanced genomic analysis platforms...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The $4,560 firm fixed-price purchase order was awarded to Nanostring Technologies, Inc., a publicly traded manufacturer of genomic analysis platforms and life science tools. The contract is for the procurement of a "CODE SET REAGENT KIT" for use in Nanostring's proprietary nCounter Analysis Systems....
- Nanostring Technologies, Inc. has been awarded a firm fixed price purchase order valued at $22,941 by the National Institutes of Health National Institute of Allergy and Infectious Diseases. The award has no set-aside designation and work is to be completed by December 31, 2023. As a manufacturer of life science tools for translational research and molecular diagnostics, Nanostring will likely provide specialized equipment, consumables, or services to support genomic and molecular analysis...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Nanostring Technologies, Inc. The $18,660 firm fixed-price purchase order is for the supply of the NANOSTRING MOUSE IMMUNOLOGY KIT, catalog number GXA-MIMI-48. This award was not set aside for any specific business type. Nanostring Technologies is a publicly traded company that specializes in advanced genomic analysis platforms and life...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The $8,813 firm fixed-price purchase order is for the delivery of AMBIS# 1552919NCOUNTER GX CODESET-48 RXNS GXA-P1CS-048, No. 100021. This order is not associated with a set-aside program. Nanostring has provided a range of products and services to various government agencies through both prime contracts and subcontract awards, including the supply of nCounter and GeoMx analysis systems, custom codesets, reagents, and consumables. The company currently holds two significant federal contract vehicles - a $596,881.45 single-award IDIQ contract with the USDA Agricultural Research Service and a $2.8 million single-award BPA with the Defense Health Agency to support diagnostics, vaccines, and therapeutics research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Funding Only Action | ($17) | 6/11/15 | |
| Not listed | Not listed | $8.8k | 4/28/11 |